Speaker illustration

Doctor Hirofumi Hioki

Teikyo University Hospital, Tokyo (Japan)

Member of:

EAPCI

Combination of pre-existing atrial fibrillation and coronary artery disease associates with poor outcome in patients who undergo TAVI

Event: ESC CONGRESS 2017

Topic: Aortic valve disease

Session: Risk stratification and prognosis after TAVI

Thumbnail

Do we need antiplatelet therapy before transcatheter aortic valve implantation?

Event: ESC CONGRESS 2016

Topic: Surgery and intervention in valve disease

Session: Aortic valve disease

Thumbnail

This platform is supported by

logo Novo Nordisk